CN110619938B - 基于血栓弹力图的血小板抑制率计算方法 - Google Patents
基于血栓弹力图的血小板抑制率计算方法 Download PDFInfo
- Publication number
- CN110619938B CN110619938B CN201911003271.1A CN201911003271A CN110619938B CN 110619938 B CN110619938 B CN 110619938B CN 201911003271 A CN201911003271 A CN 201911003271A CN 110619938 B CN110619938 B CN 110619938B
- Authority
- CN
- China
- Prior art keywords
- coagulation
- platelet
- curve
- intensity
- adp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000005764 inhibitory process Effects 0.000 title claims abstract description 57
- 238000004364 calculation method Methods 0.000 title claims abstract description 20
- 230000015271 coagulation Effects 0.000 claims abstract description 60
- 238000005345 coagulation Methods 0.000 claims abstract description 60
- 210000004369 blood Anatomy 0.000 claims abstract description 29
- 239000008280 blood Substances 0.000 claims abstract description 29
- 238000001514 detection method Methods 0.000 claims abstract description 12
- 230000001131 transforming effect Effects 0.000 claims abstract description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims description 21
- 230000035602 clotting Effects 0.000 claims description 18
- 206010053567 Coagulopathies Diseases 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 15
- 208000010110 spontaneous platelet aggregation Diseases 0.000 claims description 9
- 230000010354 integration Effects 0.000 claims description 5
- 239000003814 drug Substances 0.000 abstract description 15
- 238000007711 solidification Methods 0.000 abstract description 15
- 230000008023 solidification Effects 0.000 abstract description 15
- 238000011156 evaluation Methods 0.000 abstract description 4
- 210000001772 blood platelet Anatomy 0.000 description 59
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 42
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 31
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 31
- 229940114079 arachidonic acid Drugs 0.000 description 21
- 235000021342 arachidonic acid Nutrition 0.000 description 21
- 229940079593 drug Drugs 0.000 description 14
- 230000023555 blood coagulation Effects 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 230000006870 function Effects 0.000 description 8
- 230000008569 process Effects 0.000 description 7
- 208000007536 Thrombosis Diseases 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 102000009123 Fibrin Human genes 0.000 description 4
- 108010073385 Fibrin Proteins 0.000 description 4
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 4
- 238000004422 calculation algorithm Methods 0.000 description 4
- 229950003499 fibrin Drugs 0.000 description 4
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 3
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 3
- 230000001133 acceleration Effects 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000003114 blood coagulation factor Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 238000012896 Statistical algorithm Methods 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 229940127218 antiplatelet drug Drugs 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000002091 elastography Methods 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000000106 platelet aggregation inhibitor Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 201000005665 thrombophilia Diseases 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/4905—Determining clotting time of blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Primary Health Care (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ecology (AREA)
- Biophysics (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (2)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911003271.1A CN110619938B (zh) | 2019-10-22 | 2019-10-22 | 基于血栓弹力图的血小板抑制率计算方法 |
PCT/CN2020/090323 WO2021077728A1 (zh) | 2019-10-22 | 2020-05-14 | 基于血栓弹力图的血小板抑制率计算方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911003271.1A CN110619938B (zh) | 2019-10-22 | 2019-10-22 | 基于血栓弹力图的血小板抑制率计算方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110619938A CN110619938A (zh) | 2019-12-27 |
CN110619938B true CN110619938B (zh) | 2023-05-30 |
Family
ID=68926101
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911003271.1A Active CN110619938B (zh) | 2019-10-22 | 2019-10-22 | 基于血栓弹力图的血小板抑制率计算方法 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN110619938B (zh) |
WO (1) | WO2021077728A1 (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110619938B (zh) * | 2019-10-22 | 2023-05-30 | 常熟常江生物技术有限公司 | 基于血栓弹力图的血小板抑制率计算方法 |
CN111323570B (zh) * | 2020-03-25 | 2021-11-05 | 天津市宝坻区人民医院 | 基于血栓弹力图的阿司匹林药物抵抗检测方法 |
CN111584083A (zh) * | 2020-05-25 | 2020-08-25 | 常熟常江生物技术有限公司 | 一种血栓弹力图检测综合凝血指数积分算法 |
CN111579398B (zh) * | 2020-05-28 | 2023-04-07 | 常熟常江生物技术有限公司 | 一种体外血栓物性检测装置 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05208961A (ja) * | 1992-01-31 | 1993-08-20 | Eisai Co Ltd | イミダゾール誘導体 |
CN1784604A (zh) * | 2003-03-07 | 2006-06-07 | 希莫斯科普公司 | 监测血小板抑制的方案 |
WO2016200765A1 (en) * | 2015-06-08 | 2016-12-15 | The Regents Of The University Of Colorado, A Body Corporate | Time independent viscoelastic analysis parameter for prediction of patient outcome |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7732213B2 (en) * | 1999-02-22 | 2010-06-08 | Coramed Healthcare, Inc. | Method of evaluating patient hemostasis |
JP6526717B2 (ja) * | 2014-05-05 | 2019-06-05 | ヘモネティクス・コーポレーションHaemonetics Corporation | 線維素溶解及び線溶亢進を検出するための方法及び試薬 |
JP7009998B2 (ja) * | 2016-01-29 | 2022-01-26 | ソニーグループ株式会社 | 血液凝固系解析装置、血液凝固系解析システム、血液凝固系解析方法及び血液凝固系解析装置用パラメーターの決定方法 |
CN106885895B (zh) * | 2017-02-27 | 2019-04-05 | 常熟常江生物技术有限公司 | 血小板功能检测方法 |
CN109580924B (zh) * | 2017-09-29 | 2020-03-27 | 重庆南方数控设备有限责任公司 | 血栓弹力图凝固过程的频域参数分析方法及系统 |
CN110619938B (zh) * | 2019-10-22 | 2023-05-30 | 常熟常江生物技术有限公司 | 基于血栓弹力图的血小板抑制率计算方法 |
-
2019
- 2019-10-22 CN CN201911003271.1A patent/CN110619938B/zh active Active
-
2020
- 2020-05-14 WO PCT/CN2020/090323 patent/WO2021077728A1/zh active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05208961A (ja) * | 1992-01-31 | 1993-08-20 | Eisai Co Ltd | イミダゾール誘導体 |
CN1784604A (zh) * | 2003-03-07 | 2006-06-07 | 希莫斯科普公司 | 监测血小板抑制的方案 |
WO2016200765A1 (en) * | 2015-06-08 | 2016-12-15 | The Regents Of The University Of Colorado, A Body Corporate | Time independent viscoelastic analysis parameter for prediction of patient outcome |
Also Published As
Publication number | Publication date |
---|---|
WO2021077728A1 (zh) | 2021-04-29 |
CN110619938A (zh) | 2019-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110619938B (zh) | 基于血栓弹力图的血小板抑制率计算方法 | |
Curry et al. | The use of viscoelastic haemostatic assays in the management of major bleeding | |
US20090130645A1 (en) | Method for assessing the fibrinogen contribution in coagulation | |
US8322195B2 (en) | Apparatus and method for measuring the coagulation characteristics of a test liquid | |
KR101590487B1 (ko) | 혈액응고시간의 연장 원인의 판정법 | |
Edwards et al. | Parameters of thromboelastography in healthy newborns | |
CN109580924B (zh) | 血栓弹力图凝固过程的频域参数分析方法及系统 | |
CN110192105B (zh) | 凝血系统分析和失血量预测装置、系统、方法和程序 | |
WO2021073081A1 (zh) | 用于血栓弹力图仪的激活剂 | |
WO2015159516A1 (en) | Blood state analysis device, blood state analysis system, blood state analysis method, and storage device | |
JP2017520757A (ja) | 線維素溶解及び線溶亢進を検出するための方法及び試薬 | |
DK2474830T3 (en) | Method of determination of factor XIII deficiency states using techniques thrombelastografiske | |
US20240044867A1 (en) | Apparatus, Systems And Methods For Integrative Photo-Optical/Mechanical Test For Noncontact Measurement Of Polymerization | |
Mustafa et al. | Evaluation of platelets count and coagulation parameters among patients with liver disease | |
CN111584083A (zh) | 一种血栓弹力图检测综合凝血指数积分算法 | |
RU2012128236A (ru) | Способ оценки состояния свертывающей системы крови у пациентов, находящихся в критическом состоянии | |
RU2669796C1 (ru) | Способ определения функционального фибриногена | |
CN107102125B (zh) | 血栓弹力图仪的校准方法 | |
RU2666945C2 (ru) | Способ оценки агрегационной активности тромбоцитов | |
JP2019060887A (ja) | 血液状態解析装置、血液状態解析システム、血液状態解析方法、および該方法をコンピューターに実現させるための血液状態解析プログラム | |
Vandenheuvel et al. | Comparison of coagulation monitoring using ROTEM and Sonoclot devices in cardiac surgery: a single-centre prospective observational study | |
US10962495B2 (en) | Blood coagulation system analysis system, blood coagulation system analysis method, and blood coagulation system analysis program | |
RU2624859C1 (ru) | Способ оценки повышенного риска возникновения флеботромбозов у пациентов с ишемической болезнью сердца | |
JPH05130899A (ja) | 血液凝固測定方法 | |
Raj | Thromboelastogram I |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Gang Inventor after: Fan Zhiming Inventor after: Suo Wei Inventor after: Zhang Yifan Inventor before: Li Gang Inventor before: Li Tong Inventor before: Fan Zhiming Inventor before: Suo Wei Inventor before: Zhang Yifan |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A Method for Calculating Platelet Inhibition Rate Based on Thromboelastography Granted publication date: 20230530 Pledgee: Bank of Jiangsu Co.,Ltd. Suzhou Branch Pledgor: ZIRCON BIOTECH Co.,Ltd. Registration number: Y2024980011037 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |